Tralokinumab is effective in severe atopic dermatitis for up to 18 months, with patients who are naïve to some medications having faster benefits.

Patients with specific dermatological immune-mediated inflammatory diseases are not at increased risk of developing severe COVID-19.

In the last few months, Pfizer has won approvals in the EU and US for JAK inhibitor Cibinqo (abrocitinib) as a treatment for moderate-to-severe atopic dermatitis in adults who cannot get relief ...

Olumiant (baricitinib) has been backed by cost-effectiveness agency NICE to treat moderate to severe atopic dermatitis in adults who haven’t responded to or are ineligible for treatment with ...

With these trends in view, let’s look at the 7 most undervalued biotech stocks to invest in.

During her lecture at Fetch Charlotte, Natalie Marks, DVM, CVJ, CCFP, Elite FFC-V, shared how to utilize exam room time and a ...

What about atopic dermatitis? What exactly is it and how ... growing up on a farm seems to be somewhat protective. Growing up with a dog seems to be somewhat protective. I do think there is ...

Dogs with food-responsive atopic dermatitis, inflammatory bowel disease, or food sensitivities can benefit from limited ingredient foods. "These diseases can range from mild to severe, so check ...

About 2,300 bottles of Benadryl Liquid Elixir sold on Amazon were recalled because of faulty childproof packaging. The affected bottles were sold between July 2023 and October 2024. If you have a ...

Apr. 24, 2024 — Study identifies key pathways underlying perianal fistula, a disease complication that is more prevalent and severe in African American ... Scientists Discover the Cellular ...